Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Sinbobon Mar 29, 2012 9:34pm
225 Views
Post# 19736714

RE: RE: Risky....

RE: RE: Risky....

Risky...we come from different investment cultures and markets as well referenced during earlier sessions. We disagree on some topics. I am big enough to respect the fact that you took the time and energy to reply in some depth. I understand that you have a deep knowledge of the trading markets, some biotech and BTI and RSV in particular. Oddly we are similar in our strong convictions of that which we believe in...such as an investment. I will fight like a dog with a bone for that which I am knowledgeable of.  Also, we both know people heavily invested in BTI and perhaps some who are close to the scene. Odd juxtapositions indeed.

Your well thought out reasons and strategies make sense given this small Canadian biotech co. with very limited visibility. I  also mentioned previosly that for many, the complexities of the technology are not understood or even read by most. Its amazing how little so many know about whatever they are invested in.

Sounds like were on the same page...long... and we believe the technology is and will be a big winner. What a bummer! Just as well. I have my hands full elsewhere...and I'm getting the strong feelng that this may be my earliest, biggest gainor. I wish I had a few hundred thousand shares of it...like some of my JPMs.

April should be most interestiing indeed.

 

 

Bullboard Posts